These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 32806257)

  • 1. Lipid-based nanocarrier-mediated targeted delivery of celecoxib attenuate severity of ulcerative colitis.
    Mishra RK; Ahmad A; Kumar A; Vyawahare A; Raza SS; Khan R
    Mater Sci Eng C Mater Biol Appl; 2020 Nov; 116():111103. PubMed ID: 32806257
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Cortisone-loaded stearoyl ascorbic acid based nanostructured lipid carriers alleviate inflammatory changes in DSS-induced colitis.
    Mishra RK; Ahmad A; Kumar A; Ali A; Kanika ; Jori C; Tabrez S; Zughaibi TA; Almashjary MN; Raza SS; Khan R
    Biomater Adv; 2023 May; 148():213383. PubMed ID: 36958119
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Berberine-Loaded Nanostructured Lipid Carriers Enhance the Treatment of Ulcerative Colitis.
    Deng J; Wu Z; Zhao Z; Wu C; Yuan M; Su Z; Wang Y; Wang Z
    Int J Nanomedicine; 2020; 15():3937-3951. PubMed ID: 32581538
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Budesonide-loaded nanostructured lipid carriers reduce inflammation in murine DSS-induced colitis.
    Beloqui A; Coco R; Alhouayek M; Solinís MÁ; Rodríguez-Gascón A; Muccioli GG; Préat V
    Int J Pharm; 2013 Oct; 454(2):775-83. PubMed ID: 23694806
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Eudragit S-100 Surface Engineered Nanostructured Lipid Carriers for Colon Targeting of 5-Fluorouracil: Optimization and In Vitro and In Vivo Characterization.
    Borderwala K; Rathod S; Yadav S; Vyas B; Shah P
    AAPS PharmSciTech; 2021 Aug; 22(6):216. PubMed ID: 34386888
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Enteric-coated gelatin nanoparticles mediated oral delivery of 5-aminosalicylic acid alleviates severity of DSS-induced ulcerative colitis.
    Ahmad A; Ansari MM; Mishra RK; Kumar A; Vyawahare A; Verma RK; Raza SS; Khan R
    Mater Sci Eng C Mater Biol Appl; 2021 Feb; 119():111582. PubMed ID: 33321628
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Size-exclusive effect of nanostructured lipid carriers on oral drug delivery.
    Li H; Chen M; Su Z; Sun M; Ping Q
    Int J Pharm; 2016 Sep; 511(1):524-537. PubMed ID: 27452421
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Process, optimization, and characterization of budesonide-loaded nanostructured lipid carriers for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Chokshi NV; Khatri HN; Patel MM
    Drug Dev Ind Pharm; 2018 Jul; 44(7):1078-1089. PubMed ID: 29376433
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Surface engineered lipid nanoparticle-mediated site-specific drug delivery system for the treatment of inflammatory bowel disease.
    Sinhmar GK; Shah NN; Rawal SU; Chokshi NV; Khatri HN; Patel BM; Patel MM
    Artif Cells Nanomed Biotechnol; 2018; 46(sup2):565-578. PubMed ID: 29661024
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pectin coated nanostructured lipid carriers for targeted piperine delivery to hepatocellular carcinoma.
    Shehata EMM; Gowayed MA; El-Ganainy SO; Sheta E; Elnaggar YSR; Abdallah OY
    Int J Pharm; 2022 May; 619():121712. PubMed ID: 35367582
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preparation and Characterization of Minoxidil Loaded Nanostructured Lipid Carriers.
    Wang W; Chen L; Huang X; Shao A
    AAPS PharmSciTech; 2017 Feb; 18(2):509-516. PubMed ID: 27120090
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Enhanced therapeutic efficacy of a novel colon-specific nanosystem loading emodin on DSS-induced experimental colitis.
    Wang D; Sun M; Zhang Y; Chen Z; Zang S; Li G; Li G; Clark AR; Huang J; Si L
    Phytomedicine; 2020 Nov; 78():153293. PubMed ID: 32777486
    [TBL] [Abstract][Full Text] [Related]  

  • 13. pH-sensitive nanoparticles of curcumin-celecoxib combination: evaluating drug synergy in ulcerative colitis model.
    Gugulothu D; Kulkarni A; Patravale V; Dandekar P
    J Pharm Sci; 2014 Feb; 103(2):687-96. PubMed ID: 24375287
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Caffeic Acid-Conjugated Budesonide-Loaded Nanomicelle Attenuates Inflammation in Experimental Colitis.
    Mishra RK; Ahmad A; Kanika ; Kumar A; Vyawahare A; Sakla R; Nadeem A; Siddiqui N; Raza SS; Khan R
    Mol Pharm; 2023 Jan; 20(1):172-182. PubMed ID: 36472567
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Enhanced antifungal activity of voriconazole-loaded nanostructured lipid carriers against
    Tian B; Yan Q; Wang J; Ding C; Sai S
    Int J Nanomedicine; 2017; 12():7131-7141. PubMed ID: 29026306
    [No Abstract]   [Full Text] [Related]  

  • 16. Quality by Design (QbD)-enabled development of aceclofenac loaded-nano structured lipid carriers (NLCs): An improved dermatokinetic profile for inflammatory disorder(s).
    Garg NK; Sharma G; Singh B; Nirbhavane P; Tyagi RK; Shukla R; Katare OP
    Int J Pharm; 2017 Jan; 517(1-2):413-431. PubMed ID: 27956192
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sivelestat-loaded nanostructured lipid carriers modulate oxidative and inflammatory stress in human dental pulp and mesenchymal stem cells subjected to oxygen-glucose deprivation.
    Prakash R; Mishra RK; Ahmad A; Khan MA; Khan R; Raza SS
    Mater Sci Eng C Mater Biol Appl; 2021 Jan; 120():111700. PubMed ID: 33545859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Preparation of tripterine nanostructured lipid carriers and their absorption in rat intestine.
    Zhou L; Chen Y; Zhang Z; He J; Du M; Wu Q
    Pharmazie; 2012 Apr; 67(4):304-10. PubMed ID: 22570936
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Etoposide-loaded nanostructured lipid carriers for gastric cancer therapy.
    Jiang H; Pei L; Liu N; Li J; Li Z; Zhang S
    Drug Deliv; 2016 May; 23(4):1379-82. PubMed ID: 26162024
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Nanostructured lipid carrier mediates effective delivery of methotrexate to induce apoptosis of rheumatoid arthritis via NF-κB and FOXO1.
    Garg NK; Tyagi RK; Singh B; Sharma G; Nirbhavane P; Kushwah V; Jain S; Katare OP
    Int J Pharm; 2016 Feb; 499(1-2):301-320. PubMed ID: 26768725
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.